| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
| 5 | 369 | | Cost of Revenue | 25 | 25 | 28 | 102 | | | Gross Profit | (25) | (25) | (23) | 266 | | | Operating Expenses | | Research Development | 2,557 | 2,608 | 2,104 | 2,396 | | Selling General and Administrative | 1,315 | 1,476 | 1,443 | 1,311 | | Non Recurring | 98 | 198 | 53 | 131 | | Others | 12 | 48 | 48 | 48 | | | | Total Operating Expenses | 3,982 | 4,330 | 3,647 | 3,886 | | | | Operating Income or Loss | (4,007) | (4,355) | (3,671) | (3,620) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8) | (12) | 20 | (7) | | Earnings Before Interest And Taxes | (4,016) | (4,367) | (3,651) | (3,627) | | Interest Expense | 0 | 0 | 0 | 0 | | Income Before Tax | (4,016) | (4,367) | (3,651) | (3,628) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,016) | (4,367) | (3,651) | (3,628) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,016) | (4,367) | (3,651) | (3,628) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,016) | ($4,367) | ($3,651) | ($3,628) |
|
0.05% Nasdaq 
0.48%
Income Statement
